|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.8857 - 2.0600|
|52 Week Range||1.7800 - 7.0100|
|Beta (3Y Monthly)||0.28|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Cannabis stocks fell Tuesday, as analysts weighing in on Canopy Growth’s new chief executive took a cautious stance, highlighting the continuing challenges facing the company.
Shares in Ted Baker plummeted on Tuesday as the embattled British retailer issued another profit warning after a weaker-than-expected Black Friday.
Shares in Ted Baker took another beating on Monday after the beleaguered British retailer disclosed that its inventory had been overvalued
On November 27, 2019 Jason Wild, Chairman of TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend") acquired for his own account 50,000 shares of TerrAscend at a price of Cdn$3.42 per share. Mr. Wild is the principal of JW Asset Management Inc. which advises JW Funds, (consisting of JW Partners, LP, JW Opportunities Master Fund, Ltd., and Pharmaceutical Opportunities Fund, LP 2018). Mr. Wild purchased the shares for investment purposes.
Terrascend Corp (OTC: TRSSF ), a global cannabis company licensed for sales in Canada, the U.S. and the European Union, released its third-quarter financial report Wednesday. Q3 Highlights Revenue increased from ...
The uncertain regulatory environment in the U.S. has not stopped the cannabis industry from putting down roots in the secondary market. Today, more than 200 cannabis-related companies trade on OTC Markets—an alternative trading system that offers more efficient access to public markets for early stage companies—enabling companies to grow their shareholder base while creating liquidity for investors. According to Jason Paltrowitz, executive vice president, corporate services at OTC Markets, this trend is the direct result of legacy financial systems (such as exchanges) not always being receptive to emerging industries like cannabis.
TerrAscend Corp. (CSE: TER) (OTC: TRSSF ) said Wednesday it has entered into a strategic collaboration with Kindred Partners Inc., a cannabis brokerage and services company. Kindred will provide brokerage ...
Canadian cannabis company TerrAscend Corp. (CSE: TER) (OTC: TRSSF) announced Tuesday it has obtained an amendment to its existing Health Canada license that enables it to sell cannabis extracts, topicals and edibles. The news comes as the country kicks off “Cannabis 2.0,” legalizing edibles, beverages and other cannabis derivative products. The company submitted 15 SKUs to Health Canada for launch approval, including vape pens, edibles and cartridges.
The one-year anniversary of legal Canadian cannabis is just around the corner, and the country plans to celebrate in a big way. Legislators introduced prohibition policies in 1923, well ahead of the U.S.
Zelda Therapeutics Limited (OTC: ZLDAF), an Australian biopharmaceutical company focused on cannabinoid formulations, announced Wednesday a merger of equals with Ilera Therapeutics LLC, a private cannabis science company. With approval from Zelda’s shareholders, Zelda would acquire 100% of Ilera Therapeutics via an all-scrip — all-stock — transaction, the company said.
TerrAscend Corp. (CSE: TER) (OTC: TRSSF ) announced Monday that it has obtained Health Canada approval for expansion of its Mississauga, Ontario facility. The company plans to enlarge its facility from ...
TerrAscend Corp. (CSE: TER) (OTC: TRSSF ) said Wednesday it plans to conclude non-brokered private placement offerings to raise $25 million by issuing units of both TerrAscend and TerrAscend Canada Inc. ...
MediPharm Labs Corp. (TSX: LABS)(OTC: MEDIF) said Wednesday it has signed a supply agreement with TerrAscend Canada Inc, a subsidiary of TerrAscend Corp. (CSE: TER)(OTC: TRSSF). Per the multi-year deal, MediPharm Labs will provide TerrAscend with a minimum $27 million of high-quality private label cannabis distillate in the next two years beginning this month. TerrAscend will utilize the supply to boost its production and to bring its branded products to Canada this fall, the company said.
The company said its inhaler is the first metered-dose medical cannabis inhaler in the world that offers accurate, predictable and regular treatment that meets pharmaceutical standards. Syqe Medical launched the inhaler in June in the Israeli market and will now bring it to Canada via its collaboration with TerrAscend.
TerrAscend Corp. (CSE: TER) (OTC: TRSSF) announced Wednesday the signing of definitive agreements for a series of transactions to purchase ABI SF, LLC, which runs a Bay Area cannabis cultivation facility and owns the State Flower brand. At first, TerrAscend agreed to acquire 49.9% of the equity of State Flower for a total of $2.85 million from the conversion of already issued convertible debenture and subject to regulatory approvals, the company said in a press release. Now, it has agreed to purchase the remaining 50.1% of the equity of State Flower for total consideration based on future revenue in a predetermined period of 12 months.
Terrascend Corp (CSE:TER)(OTC: TRSSF ) said that JW Asset Management exercised early its warrants to acquire voting shares of the company. In total, JW Asset Management exercised warrants to acquire around ...
TerrAscend Corp. (CSE: TER) (OTC: TRSSF ) reported second-quarter revenue of CA $17.6 million, up 21% from CA $14.6 million in the first quarter. Its non-GAAP adjusted EBITDA was (CA $12.5 million) for ...
The next five days will still be full of news surrounding the cannabis space. We have compiled a list of main things that cannabis investors should be keeping an eye on this week. Ontario Lottery And New ...
Canada-based TerrAscend Corp (OTC:TRSSF) (CSE:TER), the first licensed for sales in Canada, the U.S. and the E.U., announced this week it's acquiring Ilera Healthcare, one of the five vertically-integrated cannabis cultivators, processors and dispensary operators in Pennsylvania. Subject to regulatory approval, the company will buy Ilera for total consideration of $125 million to $225 million, which will be paid in a combination of cash and TerrAscend shares. TerrAscend is a portfolio company of Canopy Rivers Inc (OTC: CNPOF), the investment arm of Canopy Growth Corp (NYSE: CGC).
Cannabis cultivator TerrAscend Corp. (CSE:TER)(OTC: TRSSF ) reported the completion of its previously announced non-brokered private placement. Orders totaled an approximate CA$69 million (about $93 million ...
Terrascend Corp (OTC: TRSSF ) reported first-quarter revenue of CA$14.6 million ($10.8 million) Thursday and reiterated its full-year guidance. What Happened The cannabis company said its revenue surged ...
It's a no-go for recreational marijuana in the Garden State for now. And several marijuana stocks are feeling the sting of the state's delay.
In addition to gaining access to retail dispensary brand "The Apothecarium" and four dispensaries in California and Nevada, TerrAscend will also have a vertically integrated operation in Nevada that includes cultivation and edible manufacturing facilities. TerrAscend is a biopharmaceutical and wellness company that operates a number of synergistic businesses.